Search
for
Sort by
Research 61–90 of 169
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Scarring Alopecia
- Cutaneous drug reactions
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Serum irisin level in patients with acne vulgaris
- Eyelash Trichomegaly: Unusual Feature Associated with Systemic Lupus Erythematosus Patient
- Periungual lesions secondary to chemotherapy with docetaxel
- Chemically Induced Hair Loss/Alopecia
- Hair Changes due to Drugs
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- General Dermatology
- Long-term treatment within a maximum of 96 weeks of tinea unguium with long-pulsed neodymium-doped yttrium aluminum garnet laser
- Subject Index
- Alopecias
- Index
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Epidermal growth factor, innovation and safety
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- The Clinical Presentation of Systemic Lupus Erythematosus
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- “PRIDE” Complex
- 138: Induction of cellular senescence and hair follicle stem cell dysfunction upon p14ARF and p16Ink4a expression in the skin